← Back to Search

REAL-T for Type 1 Diabetes (REAL-T Trial)

N/A

Waitlist Available

Led By Elizabeth Pyatak, PhD, OTR/L

Research Sponsored by University of Southern California

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, and 12 months

Awards & highlights

REAL-T Trial Summary

This trial will test whether a lifestyle-based telehealth intervention can improve glycemic control and psychosocial outcomes, and if these effects are retained over time.

Eligible Conditions

Type 1 Diabetes

REAL-T Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in glycemic control, using Glycated Hemoglobin (HbA1C)

Secondary outcome measures

Change in automaticity of behavior (testing blood sugar), using the "Self-Report Behavioural Automaticity Index" (SRBAI)

Change in autonomy of taking insulin and/or checking blood sugar, using the "Treatment Self-Regulation Questionnaire" (TSRQ)

Change in cost to patients

+12 more

Other outcome measures

Background Information

REAL-T Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Lifestyle InterventionExperimental Treatment1 Intervention

Resilient, Empowered, Active Living-Telehealth (REAL-T)

Group II: Usual CareActive Control1 Intervention

Participants will continue to have access to routine diabetes care from the provider of their choosing; they will not receive any study-related intervention.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Resilient, Empowered, Active Living-Telehealth (REAL-T)

2019

N/A

~210

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor

905 Previous Clinical Trials

1,596,109 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,356 Previous Clinical Trials

4,314,857 Total Patients Enrolled

Elizabeth Pyatak, PhD, OTR/LPrincipal InvestigatorUniversity of Southern California

3 Previous Clinical Trials

232 Total Patients Enrolled

Media Library

Resilient, Empowered, Active Living-Telehealth (REAL-T) Clinical Trial Eligibility Overview. Trial Name: NCT04023487 — N/A

Type 1 Diabetes Research Study Groups: Lifestyle Intervention, Usual Care

Type 1 Diabetes Clinical Trial 2023: Resilient, Empowered, Active Living-Telehealth (REAL-T) Highlights & Side Effects. Trial Name: NCT04023487 — N/A

Resilient, Empowered, Active Living-Telehealth (REAL-T) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04023487 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what count has the cohort of participants enrolled in this experiment swelled?

"Affirmative, clinicaltrials.gov data suggests that this experiment is currently recruiting participants. This research was first advertised on October 22nd 2019 and its latest update occurred November 10th 2022; 210 individuals are needed at one site to complete the trial."

Answered by AI

Is recruitment for this experiment still in progress?

"Affirmative. Per data hosted on clinicaltrials.gov, this trial is accepting new candidates since it was first posted in October 2019 and last modified in November 2022. The study requires 210 patients at 1 location to participate."

Answered by AI

Can minors access the benefits of this trial?

"Per the prerequisites of this trial, individuals must be between 18 and 30 years old. Separately, there are 216 trials open to minors as well as 921 studies available for those over 65."

Answered by AI

Am I eligible to contribute to this clinical research?

"This clinical trial requires that 210 individuals between 18 and 30 years of age, with both diabetes and an autoimmune disorder meet the following criteria: having type 1 diabetes for at least one year; hemoglobin A1c ≥7.5%; being a speaker of either Spanish or English; living in a region where occupational therapists are licensed; access to local healthcare providers; access to a laptop/desktop computer (with loaned option); willingness to participate in 6-month intervention."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluation of an Intervention for Young Adults With Diabetes: Resilient, Empowered, Active Living-Telehealth (REAL-T)

Beth Pyatak 2019. "Evaluation of an Intervention for Young Adults With Diabetes: Resilient, Empowered, Active Living-Telehealth (REAL-T)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04023487.